Company: BSX
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0000885725-25-000033
Chunk: 1

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-05-28
Form: 8-K
Item: Item 8.01
Chunk 1
---
 among other things: the financial, operational and other impacts of the decision to discontinue worldwide sales of the ACURATE valve platform and the Company’s ability to manage such impacts; economic conditions, including the impact of foreign currency fluctuations; future U. S. and global political, competitive, reimbursement and regulatory conditions, including changing trade and tariff policies; geopolitical events; manufacturing, distribution and supply chain disruptions and cost increases; disruptions caused by cybersecurity events; disruptions caused by public health emergencies or extreme weather or other climate change-related events; labor shortages and increases in labor costs; variations in outcomes of ongoing and future clinical trials and market studies; new product introductions; expected procedural volumes; the closing and integration of acquisitions; demographic trends; intellectual property; litigation; financial market conditions; the execution and effect of the Company's business strategy, including its cost-savings and growth initiatives; and future business decisions made by the Company and its competitors. New risks and uncertainties may arise from time to time and are difficult to predict accurately and many of them are beyond the Company’s control. For a further list and description of these and other important risks and uncertainties that may affect the Company’s future operations, see Part I, Item 1A - Risk Factors in its most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which the Company may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q it has filed or will file hereafter. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in its expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements, except as required by law. This cautionary statement is applicable to all forward-looking statements contained in this Current Report on Form 8-K.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      May 28, 2025      BOSTON SCIENTIFIC CORPORATION                                                                       
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                               By:                                /s/ Susan Thompson                                               
                                                                  Susan Thompson                                                   
                                                                  Vice President, Chief Corporate Counsel and Assistant Secretary